These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

575 related articles for article (PubMed ID: 16739116)

  • 1. Single or multiple injections of methamphetamine increased dopamine turnover but did not decrease tyrosine hydroxylase levels or cleave caspase-3 in caudate-putamen.
    Pereira FC; Lourenço ES; Borges F; Morgadinho T; Ribeiro CF; Macedo TR; Ali SF
    Synapse; 2006 Sep; 60(3):185-93. PubMed ID: 16739116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methamphetamine, morphine, and their combination: acute changes in striatal dopaminergic transmission evaluated by microdialysis in awake rats.
    Pereira FC; Lourenço E; Milhazes N; Morgadinho T; Ribeiro CF; Ali SF; Macedo TR
    Ann N Y Acad Sci; 2006 Aug; 1074():160-73. PubMed ID: 17105914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Escalating dose pretreatment induces pharmacodynamic and not pharmacokinetic tolerance to a subsequent high-dose methamphetamine binge.
    O'Neil ML; Kuczenski R; Segal DS; Cho AK; Lacan G; Melega WP
    Synapse; 2006 Nov; 60(6):465-73. PubMed ID: 16897726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurotoxic-related changes in tyrosine hydroxylase, microglia, myelin, and the blood-brain barrier in the caudate-putamen from acute methamphetamine exposure.
    Bowyer JF; Robinson B; Ali S; Schmued LC
    Synapse; 2008 Mar; 62(3):193-204. PubMed ID: 18081184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methamphetamine-induced loss of striatal dopamine innervation in BDNF heterozygote mice does not further reduce D3 receptor concentrations.
    Joyce JN; Renish L; Osredkar T; Walro JM; Kucera J; Dluzen DE
    Synapse; 2004 Apr; 52(1):11-9. PubMed ID: 14755628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methamphetamine-induced neurotoxicity: roles for glutamate and dopamine efflux.
    Stephans SE; Yamamoto BK
    Synapse; 1994 Jul; 17(3):203-9. PubMed ID: 7974204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of a cold environment or age on methamphetamine-induced dopamine release in the caudate putamen of female rats.
    Bowyer JF; Gough B; Slikker W; Lipe GW; Newport GD; Holson RR
    Pharmacol Biochem Behav; 1993 Jan; 44(1):87-98. PubMed ID: 8094252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute changes in dopamine release and turnover in rat caudate nucleus following a single dose of methamphetamine.
    Pereira FC; Imam SZ; Gough B; Newport GD; Ribeiro CF; Slikker W; Macedo TR; Ali SF
    J Neural Transm (Vienna); 2002 Sep; 109(9):1151-8. PubMed ID: 12203042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of chronic administration of quetiapine on the methamphetamine-induced recognition memory impairment and dopaminergic terminal deficit in rats.
    He J; Yang Y; Yu Y; Li X; Li XM
    Behav Brain Res; 2006 Sep; 172(1):39-45. PubMed ID: 16712969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methamphetamine-induced spectrin proteolysis in the rat striatum.
    Staszewski RD; Yamamoto BK
    J Neurochem; 2006 Mar; 96(5):1267-76. PubMed ID: 16417574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delta opioid peptide [D-Ala2, D-Leu5]enkephalin causes a near complete blockade of the neuronal damage caused by a single high dose of methamphetamine: examining the role of p53.
    Hayashi T; Hirata H; Asanuma M; Ladenheim B; Tsao LI; Cadet JL; Su TP
    Synapse; 2001 Mar; 39(4):305-12. PubMed ID: 11169780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of environmental temperature on the transient effects of methamphetamine on dopamine levels and dopamine release in rat striatum.
    Bowyer JF; Tank AW; Newport GD; Slikker W; Ali SF; Holson RR
    J Pharmacol Exp Ther; 1992 Feb; 260(2):817-24. PubMed ID: 1346646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epothilone D prevents binge methamphetamine-mediated loss of striatal dopaminergic markers.
    Killinger BA; Moszczynska A
    J Neurochem; 2016 Feb; 136(3):510-25. PubMed ID: 26465779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methamphetamine exposure during the preweanling period causes prolonged changes in dorsal striatal protein kinase A activity, dopamine D2-like binding sites, and dopamine content.
    Crawford CA; Williams MT; Newman ER; McDougall SA; Vorhees CV
    Synapse; 2003 Jun; 48(3):131-7. PubMed ID: 12645038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective inhibition of cyclooxygenase-2 exacerbates methamphetamine-induced dopamine depletion in the striatum in rats.
    Zhang X; Dong F; Mayer GE; Bruch DC; Ren J; Culver B
    Neuroscience; 2007 Dec; 150(4):950-8. PubMed ID: 17988800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of the 5-HT2 receptor in the methamphetamine-induced neurochemical alterations.
    Johnson M; Sonsalla PK; Letter AA; Hanson GR; Gibb JW
    J Pharmacol Exp Ther; 1994 Jul; 270(1):97-103. PubMed ID: 7913500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methamphetamine and human immunodeficiency virus protein Tat synergize to destroy dopaminergic terminals in the rat striatum.
    Theodore S; Cass WA; Maragos WF
    Neuroscience; 2006 Feb; 137(3):925-35. PubMed ID: 16338084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methamphetamine-induced rapid decrease in dopamine transporter function: role of dopamine and hyperthermia.
    Metzger RR; Haughey HM; Wilkins DG; Gibb JW; Hanson GR; Fleckenstein AE
    J Pharmacol Exp Ther; 2000 Dec; 295(3):1077-85. PubMed ID: 11082443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute neurotoxic effects of the fungal metabolite ochratoxin-A.
    Sava V; Reunova O; Velasquez A; Harbison R; Sánchez-Ramos J
    Neurotoxicology; 2006 Jan; 27(1):82-92. PubMed ID: 16140385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term changes in basal ganglia function after a neurotoxic regimen of methamphetamine.
    Chapman DE; Hanson GR; Kesner RP; Keefe KA
    J Pharmacol Exp Ther; 2001 Feb; 296(2):520-7. PubMed ID: 11160639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.